Loading clinical trials...

Headache After Diagnostic Lumbar Puncture | Clinical Trials | Clareo Health

COMPLETEDNA

Headache After Diagnostic Lumbar Puncture

The Importance of Needle Size, Needle Design and Stylet Reinsertion to Prevent Post-lumbar Puncture Headache, a Randomized Controlled Trial

NCT03960749•Jonatan Salzer

View on ClinicalTrials.gov

Summary

The objectives of this study are to investigate the effects of needle design, needle size and stylet reinsertion on the risk for headache after diagnostic LP (lumbar puncture, Post-LP headache). The following needles are used in the study: 1. Sprotte 25 Gauge (G) (0.5 mm) atraumatic needle with introducer 2. Sprotte 22 G (0.7 mm) atraumatic needle with introducer 3. Spinocan 25 G (0.5 mm) cutting needle

Eligibility

Age

16 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Subjects undergoing diagnostic LP during their neurological work-up at Umeå University Hospital, Sweden, from 28 May 2013 until the study is fully recruited and;
•Willing to participate and
•Providing informed consent

Exclusion Criteria

•Subjects unable to participate in the study follow-up

Key Dates

Start Date

May 28, 2013

Primary Completion Date

June 24, 2018

Completion Date

October 11, 2018

Last Updated

May 23, 2019

Enrollment

1,000

ACTUAL participants

Conditions

Post-Lumbar Puncture Headache

Interventions

Sprotte 25G needle, stylet reinserted

DEVICE

Sprotte 25G needle, stylet not reinserted

DEVICE

Sprotte 22G needle, stylet reinserted

DEVICE

Sprotte 22G needle, stylet not reinserted

DEVICE

Spinocan 25G needle, stylet reinserted

DEVICE

Spinocan 25G needle, stylet not reinserted

DEVICE

Pathophysiology and Treatment of Cerebrospinal Hypotension Exploration Study

NCT06805591

Spontaneous Intracranial HypotensionIntracranial Hypotension+1 more

View study

WITHDRAWNPHASE2/PHASE3

Epidural Blood Patch on the Resolution of Postdural Puncture Headache (PDPH)

NCT00373074

Post-Lumbar Puncture Headache

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 23, 2019Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions